In order to know 1) whether or 2) when to initiate and/or 3) at what times to administer treatment with antirhythmic drugs, i.e., for timely treatment and in order to weld timing to dosing, it seems mandatory to map the variation encountered under ordinary conditions in ventricular arrhythmias (VA) in each population of interest. Such maps are here provided for the clinical pharmacologist for three populations: healthy men, men with ischemic heart disease (IHD) and men at risk of developing IHD, each of these exhibiting statistically significant rhythms.
|Original language||English (US)|
|Number of pages||12|
|Journal||Advances in the Biosciences|
|State||Published - Dec 1 1982|
- ischemic heart disease
- ventricular arrhythmias